Figs, Inc. FIGS
We take great care to ensure that the data presented and summarized in this overview for FIGS, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FIGS
View all-
Bamco Inc New York, NY25.7MShares$134 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$65.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$53.7 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.1MShares$52.7 Million0.03% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN9.05MShares$47.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY4.63MShares$24.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.13MShares$16.3 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.93MShares$15.2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.71MShares$14.1 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.7MShares$14 Million0.0% of portfolio
Latest Institutional Activity in FIGS
Top Purchases
Top Sells
About FIGS
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.
Insider Transactions at FIGS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2024
|
Kevin Fosty Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,686
+22.71%
|
-
|
May 07
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
28,614
-5.75%
|
$114,456
$4.89 P/Share
|
Mar 05
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
1,824
-0.37%
|
$9,120
$5.54 P/Share
|
Mar 05
2024
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,762
-3.7%
|
$78,810
$5.54 P/Share
|
Mar 04
2024
|
Catherine Eva Spear Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
652,174
+35.45%
|
-
|
Feb 08
2024
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,201
-0.98%
|
$25,206
$6.0 P/Share
|
Feb 06
2024
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
27,547
-5.23%
|
$137,735
$5.93 P/Share
|
Jan 05
2024
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,201
-0.97%
|
$25,206
$6.08 P/Share
|
Dec 06
2023
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,601
-1.72%
|
$53,207
$7.0 P/Share
|
Dec 05
2023
|
Catherine Eva Spear Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
169,076
-24.0%
|
-
|
Dec 05
2023
|
Heather L. Hasson Executive Chair |
SELL
Other acquisition or disposition
|
Direct |
98,227
-15.71%
|
-
|
Dec 04
2023
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,933
-2.42%
|
$76,531
$7.39 P/Share
|
Dec 04
2023
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
73,802
-10.56%
|
$516,614
$7.39 P/Share
|
Dec 01
2023
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
380,010
-35.22%
|
$2,660,070
$7.4 P/Share
|
Nov 07
2023
|
Heather L. Hasson Executive Chair |
SELL
Open market or private sale
|
Direct |
40,691
-3.63%
|
$244,146
$6.54 P/Share
|
Nov 07
2023
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,201
-0.92%
|
$25,206
$6.71 P/Share
|
Nov 03
2023
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,807
-0.61%
|
$19,649
$7.0 P/Share
|
Nov 03
2023
|
Mario Jesus Marte Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,035
+50.0%
|
-
|
Oct 11
2023
|
Daniella Turenshine Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,122
+5.2%
|
$0
$0.64 P/Share
|
Oct 06
2023
|
Daniella Turenshine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,201
-1.01%
|
$25,206
$6.02 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 684K shares |
---|---|
Grant, award, or other acquisition | 794K shares |
Other acquisition or disposition | 802K shares |
---|---|
Open market or private sale | 1.48M shares |